Form 4: Vertex Pharmaceuticals Inc / Ma Director Receives Stock Gran
Insider Transaction (Form 4)
Alan M Garber, a Director of Vertex Pharmaceuticals Inc / Ma, received 32 shares of common stock on July 15, 2026.
Summary
- Grant/award: acquired 32 Deferred Stock Units at $475.28 ($15,000) on July 15, 2026; holds 65 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alan M Garber — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Deferred Stock Units | 31.56 | $475 | $15.0K | 65.458 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (32 shares) |
Keywords
insider transaction, Form 4, VRTX, VERTEX PHARMACEUTICALS INC / MA, neutral, Alan M Garber
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.